Prognostic value of human epidermal growth factor receptor 2 (Her-2)/neu in patients with advanced ovarian cancer treated with platinum/paclitaxel as first-line chemotherapy: a retrospective evaluation of the AGO-OVAR 3 Trial by the AGO OVAR Germany.

Pfisterer, Jacobus; Du Bois, Andreas; Bentz, Eva-Katrin; Kommoss, Friedrich; Harter, Philipp; Huober, Jens; Schmalfeldt, Barbara; Burchardi, Nicole; Arnold, Norbert; Hilpert, Felix

Pfisterer, Jacobus; Du Bois, Andreas; Bentz, Eva-Katrin; Kommoss, Friedrich; Harter, Philipp; Huober, Jens; Schmalfeldt, Barbara; Burchardi, Nicole; Arnold, Norbert; Hilpert, Felix.

Affiliation

Pfisterer J; Klinik für Gynäkologie und Geburtshilfe, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany.

Int J Gynecol Cancer ; 19(1): 109-15, 2009 Jan.

Article in En | MEDLINE | ID: mdl-19258951

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Biomarkers, Tumor/analysis; Genes, erbB-2; Ovarian Neoplasms/drug therapy; Aged; Carboplatin/administration & dosage; Cisplatin/administration & dosage; Female; Humans; Middle Aged; Ovarian Neoplasms/pathology; Ovarian Neoplasms/surgery; Paclitaxel/administration & dosage; Predictive Value of Tests; Prognosis; Prospective Studies

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Genes, erbB-2 Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Int J Gynecol Cancer Journal subject: GINECOLOGIA / NEOPLASIAS Year: 2009 Type: Article Affiliation country: Germany

Fulltext

XML

PubMed Links

Search on Google